Acyl chain-dependent effect of lysophosphatidylcholine on cyclooxygenase (COX)-2 expression in endothelial cells

Atherosclerosis

Volumn 224, Issue 2, 2012, Pages 348-354

  Brkić, Lada ^a   Riederer, Monika ^a   Graier, Wolfgang F ^a   Malli, Roland ^a   Frank, Saša ^a,b  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

^b University of Applied Sciences   (Austria)

Author keywords

Acyl chain; Calcium; Cell signaling; COX 2; Endothelial cells; Lysophosphatidylcholine

Indexed keywords

CALCIUM ION; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; CYCLOOXYGENASE 2; LYSOPHOSPHATIDYLCHOLINE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE P38; PHOSPHOLIPASE C; PROTEIN C JUN; TRANSCRIPTION FACTOR RELA;

ARTICLE; CALCIUM CELL LEVEL; ENZYME ACTIVATION; ENZYME INDUCTION; ENZYME INHIBITION; GENE SILENCING; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA SYNTHESIS; VASCULAR ENDOTHELIUM;

CALCIUM; CELL LINE; CHELATING AGENTS; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; CYCLOOXYGENASE 2; ENDOTHELIAL CELLS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; KINETICS; LYSOPHOSPHATIDYLCHOLINES; MOLECULAR STRUCTURE; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PROTEIN KINASE INHIBITORS; RNA INTERFERENCE; RNA, MESSENGER; STRUCTURE-ACTIVITY RELATIONSHIP; TRANSCRIPTION FACTOR RELA; TRANSFECTION; UP-REGULATION;

EID: 84866561512     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2012.07.038     Document Type: Article

References (30)

1. Sato H., Kato R., Isogai Y., et al. Analyses of group III secreted phospholipase A2 transgenic mice reveal potential participation of this enzyme in plasma lipoprotein modification, macrophage foam cell formation, and atherosclerosis. J Biol Chem 2008, 283(48):33483-33497.
2. Rousset X., Vaisman B., Amar M., Sethi A.A., Remaley A.T. Lecithin: cholesterol acyltransferase-from biochemistry to role in cardiovascular disease. Curr Opin Endocrinol Diabetes Obes 2009, 16(2):163-171.
3. Parthasarathy S., Steinbrecher U.P., Barnett J., Witztum J.L., Steinberg D. Essential role of phospholipase A2 activity in endothelial cell-induced modification of low density lipoprotein. Proc Natl Acad Sci U S A 1985, 82(9):3000-3004.
4. Gauster M., Rechberger G., Sovic A., et al. Endothelial lipase releases saturated and unsaturated fatty acids of high density lipoprotein phosphatidylcholine. J Lipid Res 2005, 46(7):1517-1525.
5. Santamarina-Fojo S., Gonzalez-Navarro H., Freeman L., Wagner E., Nong Z. Hepatic lipase, lipoprotein metabolism, and atherogenesis. Arterioscler Thromb Vasc Biol 2004, 24(10):1750-1754. Epub 2004/07/31.
6. Ojala P.J., Hirvonen T.E., Hermansson M., Somerharju P., Parkkinen J. Acyl chain-dependent effect of lysophosphatidylcholine on human neutrophils. J Leukoc Biol 2007, 82(6):1501-1509.
7. Chen L., Liang B., Froese D.E., et al. Oxidative modification of low density lipoprotein in normal and hyperlipidemic patients: effect of lysophosphatidylcholine composition on vascular relaxation. J Lipid Res 1997, 38(3):546-553.
8. Ojala P.J., Hermansson M., Tolvanen M., et al. Identification of alpha-1 acid glycoprotein as a lysophospholipid binding protein: a complementary role to albumin in the scavenging of lysophosphatidylcholine. Biochemistry 2006, 45(47):14021-14031.
9. Croset M., Brossard N., Polette A., Lagarde M. Characterization of plasma unsaturated lysophosphatidylcholines in human and rat. Biochem J 2000, 345(Pt 1):61-67.
10. Riederer M., Lechleitner M., Hrzenjak A., et al. Endothelial lipase (EL) and EL-generated lysophosphatidylcholines promote IL-8 expression in endothelial cells. Atherosclerosis 2011, 214(2):338-344.
11. Murugesan G., Sandhya Rani M.R., Gerber C.E., et al. Lysophosphatidylcholine regulates human microvascular endothelial cell expression of chemokines. J Mol Cell Cardiol 2003, 35(11):1375-1384.
12. Zembowicz A., Jones S.L., Wu K.K. Induction of cyclooxygenase-2 in human umbilical vein endothelial cells by lysophosphatidylcholine. J Clin Invest 1995, 96(3):1688-1692.
13. Rikitake Y., Hirata K., Kawashima S., et al. Signaling mechanism underlying COX-2 induction by lysophosphatidylcholine. Biochem Biophys Res Commun 2001, 281(5):1291-1297.
14. Ghosh M., Wang H., Ai Y., et al. COX-2 suppresses tissue factor expression via endocannabinoid-directed PPARdelta activation. J Exp Med 2007, 204(9):2053-2061.
15. Alfranca A., Iniguez M.A., Fresno M., Redondo J.M. Prostanoid signal transduction and gene expression in the endothelium: role in cardiovascular diseases. Cardiovasc Res 2006, 70(3):446-456.
16. McAdam B.F., Catella-Lawson F., Mardini I.A., Kapoor S., Lawson J.A., FitzGerald G.A. Systemic biosynthesis of prostacyclin by cyclooxygenase (COX)-2: the human pharmacology of a selective inhibitor of COX-2.[erratum appears in Proc Natl Acad Sci U S A 1999 May 11;96(10):5890]. Proc Natl Acad Sci U S A 1999, 96(1):272-277.
17. Kosaka T., Miyata A., Ihara H., et al. Characterization of the human gene (PTGS2) encoding prostaglandin-endoperoxide synthase 2. Eur J Biochem 1994, 221(3):889-897.
18. Riederer M., Ojala P.J., Hrzenjak A., et al. Acyl chain-dependent effect of lysophosphatidylcholine on endothelial prostacyclin production. J Lipid Res 2010, 51(10):2957-2966.
19. Edgell C.J., McDonald C.C., Graham J.B. Permanent cell line expressing human factor VIII-related antigen established by hybridization. Proc Natl Acad Sci U S A 1983, 80(12):3734-3737.
20. Graier W.F., Schmidt K., Kukovetz W.R. Effect of sodium fluoride on cytosolic free Ca2(+)-concentrations and cGMP-levels in endothelial cells. Cell Signal 1990, 2(4):369-375. Epub 1990/01/01.
21. Knot H.J., Laher I., Sobie E.A., et al. Twenty years of calcium imaging: cell physiology to dye for. Mol Interv 2005, 5(2):112-127. Epub 2005/04/12.
22. 2+ response amplitude and duration. Nature 1997, 386(6627):855-858. Epub 1997/04/24.
23. Rabini R.A., Galassi R., Fumelli P., et al. Reduced Na(+)-K(+)-ATPase activity and plasma lysophosphatidylcholine concentrations in diabetic patients. Diabetes 1994, 43(7):915-919.
24. Wilsher N.E., Court W.J., Ruddle R., et al. The phosphoinositide-specific phospholipase C inhibitor U73122 (1-(6-((17beta-3-methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl)-1H-pyrrole-2,5-d ione) spontaneously forms conjugates with common components of cell culture medium. Drug Metab Dispos 2007, 35(7):1017-1022.
25. Yamakawa T., Ohnaka K., Tanaka S., Utsunomiya H., Kamei J., Kadonosono K. Cyclooxygenase-2 induction by lysophosphatidylcholine in cultured rat vascular smooth muscle cells: involvement of the p38MAPK pathway. Biomed Res 2008, 29(1):1-8.
26. Zarubin T., Han J. Activation and signaling of the p38 MAP kinase pathway. Cell Res 2005, 15(1):11-18.
27. Chinenov Y., Kerppola T.K. Close encounters of many kinds: fos-Jun interactions that mediate transcription regulatory specificity. Oncogene 2001, 20(19):2438-2452. Epub 2001/06/13.
28. Angel P., Karin M. The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation. Biochim Biophys Acta 1991, 1072(2-3):129-157. Epub 1991/12/10.
29. Hai T., Curran T. Cross-family dimerization of transcription factors Fos/Jun and ATF/CREB alters DNA binding specificity. Proc Natl Acad Sci U S A 1991, 88(9):3720-3724. Epub 1991/05/01.
30. Solomon S.D., Pfeffer M.A., McMurray J.J., et al. Effect of celecoxib on cardiovascular events and blood pressure in two trials for the prevention of colorectal adenomas. Circulation 2006, 114(10):1028-1035. Epub 2006/09/01.